FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 48 filers reported holding FOGHORN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $390,230 | +7.8% | 67,866 | +25.8% | 0.00% | – |
Q1 2024 | $362,092 | +4.0% | 53,963 | 0.0% | 0.00% | – |
Q4 2023 | $348,061 | +30.2% | 53,963 | +0.9% | 0.00% | – |
Q3 2023 | $267,400 | -29.0% | 53,480 | 0.0% | 0.00% | – |
Q2 2023 | $376,499 | +113303.3% | 53,480 | 0.0% | 0.00% | – |
Q1 2023 | $332 | -3.8% | 53,480 | -0.9% | 0.00% | – |
Q4 2022 | $345 | -99.9% | 53,963 | -5.4% | 0.00% | – |
Q3 2022 | $490,000 | -39.6% | 57,053 | -4.3% | 0.00% | – |
Q2 2022 | $811,000 | -46.6% | 59,604 | -47.2% | 0.00% | – |
Q1 2022 | $1,520,000 | +81.6% | 112,874 | +140.2% | 0.00% | – |
Q4 2021 | $837,000 | +18.1% | 46,987 | -12.3% | 0.00% | – |
Q3 2021 | $709,000 | +17.8% | 53,574 | -5.0% | 0.00% | – |
Q2 2021 | $602,000 | +285.9% | 56,410 | +377.8% | 0.00% | – |
Q1 2021 | $156,000 | -34.7% | 11,807 | 0.0% | 0.00% | – |
Q4 2020 | $239,000 | – | 11,807 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Capital LLC | 1,261,261 | $10,822,000 | 10.05% |
Flagship Pioneering Inc. | 12,674,120 | $108,744,000 | 4.58% |
Birchview Capital, LP | 264,843 | $2,272,000 | 1.60% |
Artal Group S.A. | 1,720,720 | $14,764,000 | 0.63% |
Rockwood Wealth Management, LLC | 124,030 | $1,064,178 | 0.34% |
Alphabet Inc. | 500,901 | $4,298,000 | 0.22% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 777,525 | $6,671,000 | 0.13% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 330,051 | $2,832,000 | 0.04% |
Virtus ETF Advisers LLC | 8,258 | $71,000 | 0.03% |
Point72 Asset Management, L.P. | 388,600 | $3,334,000 | 0.01% |